georgejjl
10 minutes ago
Next Thursday 16 January 2025 at noon EST, Anavex will present topline long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial at the J.P. Morgan 2025 Healthcare Conference, taking place January 13–16, 2025, in San Francisco, CA.
The presentation will highl